These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25053532)
21. [FGF/FGFR signalling: Implication in oncogenesis and perspectives]. Flippot R; Kone M; Magné N; Vignot S Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739 [TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets. Tenhagen M; van Diest PJ; Ivanova IA; van der Wall E; van der Groep P Endocr Relat Cancer; 2012 Aug; 19(4):R115-29. PubMed ID: 22508544 [TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factors and their receptors in cancer. Wesche J; Haglund K; Haugsten EM Biochem J; 2011 Jul; 437(2):199-213. PubMed ID: 21711248 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488 [TBL] [Abstract][Full Text] [Related]
25. Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Tiong KH; Mah LY; Leong CO Apoptosis; 2013 Dec; 18(12):1447-68. PubMed ID: 23900974 [TBL] [Abstract][Full Text] [Related]
26. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Brooks AN; Kilgour E; Smith PD Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515 [TBL] [Abstract][Full Text] [Related]
27. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. Ronca R; Giacomini A; Rusnati M; Presta M Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971 [TBL] [Abstract][Full Text] [Related]
28. Targeting FGFR Signaling in Cancer. Touat M; Ileana E; Postel-Vinay S; André F; Soria JC Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430 [TBL] [Abstract][Full Text] [Related]
29. The expression of fibroblast growth factor receptors during early bovine conceptus development and pharmacological analysis of their actions on trophoblast growth in vitro. Ozawa M; Yang QE; Ealy AD Reproduction; 2013 Feb; 145(2):191-201. PubMed ID: 23241344 [TBL] [Abstract][Full Text] [Related]
30. FGFR signalling in women's cancers. Fearon AE; Gould CR; Grose RP Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254 [TBL] [Abstract][Full Text] [Related]
33. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis. Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Gauglhofer C; Sagmeister S; Schrottmaier W; Fischer C; Rodgarkia-Dara C; Mohr T; Stättner S; Bichler C; Kandioler D; Wrba F; Schulte-Hermann R; Holzmann K; Grusch M; Marian B; Berger W; Grasl-Kraupp B Hepatology; 2011 Mar; 53(3):854-64. PubMed ID: 21319186 [TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor receptors and their ligands in the adult rat kidney. Cancilla B; Davies A; Cauchi JA; Risbridger GP; Bertram JF Kidney Int; 2001 Jul; 60(1):147-55. PubMed ID: 11422746 [TBL] [Abstract][Full Text] [Related]
36. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer. André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459 [TBL] [Abstract][Full Text] [Related]
39. Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs. Fons P; Gueguen-Dorbes G; Herault JP; Geronimi F; Tuyaret J; Frédérique D; Schaeffer P; Volle-Challier C; Herbert JM; Bono F J Cell Physiol; 2015 Jan; 230(1):43-51. PubMed ID: 24760775 [TBL] [Abstract][Full Text] [Related]
40. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Billottet C; Janji B; Thiery JP; Jouanneau J Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]